The Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta has been named a host institution for a collaborative international study sponsored by Novartis. This is a clinical trial analyzing the safety and effectiveness of an investigational cellular therapy treatment for children fighting cancer.

After 15 years of dedicated service, William G. Woods, M.D., has stepped down as director of the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and chief of hematology/oncology/BMT in the Department of Pediatrics at Emory University. He will be succeeded by Douglas Graham, M.D., Ph.D.

Children’s is incorporating Ekso—a wearable robot—or exoskeleton— into its Center for Advanced Technology and Robotic Rehabilitation to continue offering the latest technology to help children and teens recover from injuries or disorders that have hindered their motor skills.

Children’s Healthcare of Atlanta has selected Ron Frieson to become the next President of the Children’s Healthcare of Atlanta Foundation. Frieson, who currently is serving as the organization’s Chief Public Policy Officer, will succeed Gene Hayes who will retire at the end of 2015.

A new study published today in the New England Journal of Medicine could lead to therapeutic treatment options for children and adolescents allergic to peanuts.

300